“PASI Improvement in the First 12 Weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s237, https://doi.org/10.25251/skin.7.supp.237.